updating their plans for Gal should be forefront for ila right now. If they can be approved via the animal rule, where they don't need to spend on clinical human trials, they can obtain a PRV with an average of $110m US. Fairly bananas the instant payout generated if this pays off.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 13.0¢ | $52.62K | 392.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 461802 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.48pm 27/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |